February 03, 2025

Cancer Symptoms Mistaken for Pregnancy Symptoms Could Lead to Delays in Cancer Diagnosis

Pregnant patients may be at risk of having their cancer symptoms misdiagnosed as pregnancy-related symptoms.

The ASCO Post

February 03, 2025

Salpingectomy During Other Abdominal Surgeries May Lower Ovarian Cancer Risk

Researchers have examined whether fallopian tube removal performed during other abdominal surgeries could reduce the risk of ovarian cancer incidence.

The ASCO Post

February 03, 2025

Neonatal Protein Intake Linked to Preterm Brain Development

A recent study published in JAMA Network Open revealed that higher neonatal protein intake in very preterm children was associated with thinner lateral occipital and parietal cortices at 7 years, highlighting potential neurodevelopmental implications.

Conexiant

January 31, 2025

Fresh vs. Frozen Embryo Transfer: IVF Outcomes

Fresh embryo transfer may improve live birth rates over frozen transfer in women with low ovarian reserve undergoing in vitro fertilization.

Conexiant

January 31, 2025

U.S. Breast Cancer Incidence Rising Disparately Across Races and Ethnicities, Study Finds

Breast cancer incidence rates increased 0.5% annually from 2010 to 2019 in a large cohort of U.S. women, but Hispanic, Native American, and Asian women experienced disproportionately higher increases.

Conexiant

January 29, 2025

Study Explores Risk of Cervical Cancer in TMGD Individuals

Researchers found "no increased risk of invasive cervical cancer or high-grade cervical intraepithelial neoplasia in transmasculine and gender-diverse (TMGD) [individuals] using gender-affirming hormone therapy," but added that the findings should be interpreted with caution.

Conexiant

January 29, 2025

Autism Risk Differs Across Antiseizure Meds

Prenatal exposure to valproate increases autism risk, while topiramate and lamotrigine show no significant link, study finds.

Conexiant

January 29, 2025

Study Compares Surgical Approaches for Low-Risk Cervical Cancer

Simple hysterectomy was not inferior to radical hysterectomy in 3-year pelvic recurrence rates, concluded a multicenter trial.

Conexiant

January 29, 2025

COVID Research: FDA Issues Warning Letter for Clinical Trial Violations

The FDA inspected a research site and found that the trial did not meet the required ethical and procedural standards.

Conexiant